drugset / Trial / NCT00383019

A Study Comparing Xalacom And Xalatan In Patients With Primary Open Angle Glaucoma (POAG) Or Ocular Hypertension (OH).

NCT00383019

Phase 3 Completed 300 enrolled Viatris Inc.
RandomizedParallel-groupDouble-blindTreatment

Summary

This study will examine the efficacy and safety of Xalacom comparing with those of Xalatan in Japanese patients with POAG or OH, in order to show superiority of Xalacom over Xalatan in efficacy and similarity of safety between Xalacom and Xalatan.

Timeline

Start
2006-11-14
Primary completion
2007-10-01
Completion
2007-10-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Latanoprost Small molecule 0.005 %
Subject Timolol Other / unclassified 0.5 %